Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

about

NOREVA: normalization and evaluation of MS-based metabolomics data.Comparative metabolomics revealing Staphylococcus aureus metabolic response to different antibiotics.

P2860

Q34556970-C2C1E434-E026-4964-B7B6-04A242CF1591 Q43069074-171A9269-A0D1-4E36-8F54-6EDB4E599DD6

P2860

Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

Item

http://www.wikidata.org/entity/Q40338828

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Candidate serum metabolite bio ...... sia/esophageal adenocarcinoma.

@en

type

Item

label

Candidate serum metabolite bio ...... sia/esophageal adenocarcinoma.

@en

prefLabel

Candidate serum metabolite bio ...... sia/esophageal adenocarcinoma.

@en

P1476

Candidate serum metabolite bio ...... sia/esophageal adenocarcinoma.

@en

P2093

Brian J Reid

http://www.w3.org/2001/XMLSchema#string

Daniel Raftery

http://www.w3.org/2001/XMLSchema#string

Danijel Djukovic

http://www.w3.org/2001/XMLSchema#string

Haiwei Gu

http://www.w3.org/2001/XMLSchema#string

Jiangjiang Zhu

http://www.w3.org/2001/XMLSchema#string

Lynn Onstad

http://www.w3.org/2001/XMLSchema#string

Thomas L Vaughan

http://www.w3.org/2001/XMLSchema#string

P2860

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Regularization Paths for Generalized Linear Models via Coordinate Descent

ROCR: visualizing classifier performance in R

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.

Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON).

Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis.

Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.

P2888

s11306-016-1154-y

P31

scholarly article

P356

10.1007/S11306-016-1154-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew F Buas

P577

2017-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28190989

http://www.w3.org/2001/XMLSchema#string

P921

gastroesophageal reflux disease

biomarker

P932

5295138

http://www.w3.org/2001/XMLSchema#string

Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

about

P2860

P2860

Candidate serum metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett's esophagus, and high-grade dysplasia/esophageal adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P433

P478

P50

P577

P698

P921

P932